Research map: A Dynamic Prognostic and Adaptive Treatment Framework for Advanced Biliary Tract Cancer

Back to the article

Papers in this map

  1. Cancer-related inflammation · Alberto Mantovani · 2008 · 11487 citations · Cited by this paper
  2. Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort · 2026 · Related
  3. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer · Juan W. Valle · 2010 · 4493 citations · Cited by this paper
  4. Interleukin-8–driven monocyte activation in primary sclerosing cholangitis: Insights from single-cell analysis and humanized immune system mice · 2026 · Related
  5. Cancer-related inflammation and treatment effectiveness · Connie Irene Diakos · 2014 · 2233 citations · Cited by this paper
  6. A hepatocyte-derived GPNMB–RYK signaling axis in MASH progression · 2026 · Related
  7. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer · Do‐Youn Oh · 2022 · 1210 citations · Cited by this paper
  8. Development and psychometric evaluation of the Liver Disease Stigma Scale (LDSS) · 2026 · Related
  9. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial · Robin Kate Kelley · 2023 · 1156 citations · Cited by this paper
  10. Global Trends in National Alcohol Control Policies Between 2010–2019 · 2026 · Related
  11. Drug-induced liver injury · Raúl J. Andrade · 2019 · 839 citations · Cited by this paper
  12. Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury? · 2026 · Related
  13. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors · Eléonora De Martin · 2018 · 551 citations · Cited by this paper
  14. Peripartum ALT Flares Predict Earlier Postpartum HBeAg Clearance in Highly Viremic HBV-Infected Women: A Long-term Follow-up Study · 2026 · Related
  15. Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time-to-Event Data · Dimitris Rizopoulos · 2011 · 462 citations · Cited by this paper
  16. The Use of FGF21 Analogues in MASH and MASH Cirrhosis – Metabolic Master Regulators or Liver-Specific Mechanisms? ☆ · 2026 · Related
  17. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease · Jianping Jia · 2024 · 452 citations · Cited by this paper
  18. Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B · 2026 · Related
  19. Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma · Sylvie Job · 2019 · 338 citations · Cited by this paper
  20. Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study · Do‐Youn Oh · 2024 · 299 citations · Cited by this paper
  21. Immunology and immunotherapy of cholangiocarcinoma · Tim F. Greten · 2023 · 201 citations · Cited by this paper
  22. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma · Ainhoa Lapitz · 2023 · 186 citations · Cited by this paper
  23. Bilirubin: The yellow hormone? · Libor Vı́tek · 2021 · 146 citations · Cited by this paper
  24. C reactive protein impairs adaptive immunity in immune cells of patients with melanoma · Tatsuya Yoshida · 2020 · 101 citations · Cited by this paper
  25. PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival · Francesco Fiz · 2022 · 78 citations · Cited by this paper
  26. Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study · Marc Raynaud · 2021 · 75 citations · Cited by this paper
  27. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers · Takaki Akamine · 2018 · 68 citations · Cited by this paper
  28. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study · Chunxia Li · 2023 · 61 citations · Cited by this paper
  29. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma · Xu Yang · 2024 · 48 citations · Cited by this paper
  30. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study · Miloš Branković · 2017 · 43 citations · Cited by this paper
  31. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer · Li‐Tzong Chen · 2024 · 37 citations · Cited by this paper
  32. Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score · Zhengfeng Zhang · 2023 · 18 citations · Cited by this paper
  33. Longitudinal Cervical Length Measurements and Spontaneous Preterm Birth in Singleton and Twin Pregnancies · Tianchen Wu · 2024 · 15 citations · Cited by this paper
  34. DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy · Yang Yang · 2022 · 12 citations · Cited by this paper
  35. A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index · Mara Persano · 2025 · 11 citations · Cited by this paper
  36. Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma · Tianmei Zeng · 2022 · 10 citations · Cited by this paper
  37. Prompt mechanisms in medical imaging: A comprehensive survey · Hao Yang · 2026 · 5 citations · Cited by this paper
  38. Artificial intelligence and multi-omics driven models would be the future of intrahepatic cholangiocarcinoma prediction research · Zongren Ding · 2024 · 4 citations · Cited by this paper
  39. Relationship between updated MELD and prognosis in alcohol-associated hepatitis: Opportunities for more efficient trial design · Mustafa Al‐Karaghouli · 2024 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)